Sven Andreasson has been appointed senior vice president, Corporate Development at Novavax, effective June 2, 2014. Mr. Andreasson will be responsible for identifying and evaluating new strategic opportunities leveraging the company’s core strengths and growth initiatives.   Mr. Andreasson has extensive experience in biopharmaceutical operations, executive management and strategic development. He has served as executive officer of Isconova AB in Uppsala, Sweden, an international vaccine ad...